Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent

Perrigo Co. PLC's generic equivalent of Johnson & Johnson’s OTC Imodium Multi-Symptom Relief – recently approved by FDA for symptoms of diarrhea plus bloating, pressure and cramps – soon will be available in US stores.

Containing loperamide hydrochloride 2 mg for control and relief of diarrhea and simethicone 125 mg to relieve pain associated with gas, the formula will be marketed as a store brand or retailer “own label”